Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment
Authors
Keywords
-
Journal
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
Volume 136, Issue 3, Pages 277-293
Publisher
Archives of Pathology and Laboratory Medicine
Online
2012-02-28
DOI
10.5858/arpa.2011-0215-ra
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma
- (2015) Wen-Bin Ou et al. NEOPLASIA
- Proteasome Inhibitor MG132 Induces Apoptosis and Inhibits Invasion of Human Malignant Pleural Mesothelioma Cells
- (2014) Bao-Zhu Yuan et al. Translational Oncology
- Syntenic Relationships between Genomic Profiles of Fiber-Induced Murine and Human Malignant Mesothelioma
- (2011) Didier Jean et al. AMERICAN JOURNAL OF PATHOLOGY
- LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
- (2011) H. Murakami et al. CANCER RESEARCH
- SV40 associated miRNAs are not detectable in mesotheliomas
- (2010) G V Gee et al. BRITISH JOURNAL OF CANCER
- Sorafenib inhibits ERK1/2 and MCL-1L phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma
- (2010) Sharyn I. Katz et al. CANCER BIOLOGY & THERAPY
- Integrated Profiling Reveals a Global Correlation between Epigenetic and Genetic Alterations in Mesothelioma
- (2010) B. C. Christensen et al. CANCER RESEARCH
- hsa-miR-29c* Is Linked to the Prognosis of Malignant Pleural Mesothelioma
- (2010) H. I. Pass et al. CANCER RESEARCH
- Downregulation of Bcl-x L and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy
- (2010) Emilie Varin et al. CARCINOGENESIS
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Fluorescence In Situ Hybridization in the Definitive Diagnosis of Malignant Mesothelioma in Effusion Cytology
- (2010) Spasenija Savic et al. CHEST
- Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
- (2010) Gretchen V. Gee et al. INTERNATIONAL JOURNAL OF CANCER
- Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma
- (2010) Sergey V. Ivanov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells
- (2010) Ryoji Eguchi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma
- (2010) C. T.-S. Chung et al. JOURNAL OF CLINICAL PATHOLOGY
- A Diagnostic Assay Based on MicroRNA Expression Accurately Identifies Malignant Pleural Mesothelioma
- (2010) Hila Benjamin et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- In Arrayed Ranks: Array Technology in the Study of Mesothelioma
- (2010) Steven G. Gray et al. Journal of Thoracic Oncology
- Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials
- (2010) Paul K. Paik et al. Journal of Thoracic Oncology
- Antiproliferative effect of Aurora kinase targeting in mesothelioma
- (2010) Stefania Crispi et al. LUNG CANCER
- 9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis
- (2010) Maiko Takeda et al. PATHOLOGY INTERNATIONAL
- Second Generation Sequencing of the Mesothelioma Tumor Genome
- (2010) Raphael Bueno et al. PLoS One
- Identification of Potential Therapeutic Targets in Malignant Mesothelioma Using Cell-Cycle Gene Expression Analysis
- (2009) Solange Romagnoli et al. AMERICAN JOURNAL OF PATHOLOGY
- MicroRNA Signature of Malignant Mesothelioma with Potential Diagnostic and Prognostic Implications
- (2009) Sara Busacca et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Differentiation of Lung Adenocarcinoma, Pleural Mesothelioma, and Nonmalignant Pulmonary Tissues Using DNA Methylation Profiles
- (2009) B. C. Christensen et al. CANCER RESEARCH
- Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma
- (2009) Y. Goto et al. CANCER RESEARCH
- Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells
- (2009) Yoshitaka Sekido CANCER SCIENCE
- Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells
- (2009) Koji Kawaguchi et al. CARCINOGENESIS
- Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates
- (2009) J Daubriac et al. CELL DEATH AND DIFFERENTIATION
- Protumorigenic Role of HAPLN1 and Its IgV Domain in Malignant Pleural Mesothelioma
- (2009) A. V. Ivanova et al. CLINICAL CANCER RESEARCH
- Molecular Targets in Malignant Pleural Mesothelioma Treatment
- (2009) Giulia Pasello et al. CURRENT DRUG TARGETS
- Suppression of the mouse double minute 4 gene causes changes in cell cycle control in a human mesothelial cell line responsive to ultraviolet radiation exposure
- (2009) Melisa Bunderson-Schelvan et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- CDKN2A,NF2, andJUNare dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis
- (2009) Mohamed Guled et al. GENES CHROMOSOMES & CANCER
- Mesothelioma Cells Escape Heat Stress by Upregulating Hsp40/Hsp70 Expression via Mitogen-Activated Protein Kinases
- (2009) Michael Roth et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Four-Gene Expression Ratio Test for Survival in Patients Undergoing Surgery for Mesothelioma
- (2009) G. J. Gordon et al. JNCI-Journal of the National Cancer Institute
- A Histone Deacetylase Inhibitor LBH589 Downregulates XIAP in Mesothelioma Cell Lines Which is Likely Responsible for Increased Apoptosis With TRAIL
- (2009) James Symanowski et al. Journal of Thoracic Oncology
- Malignant pleural mesothelioma: Genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets
- (2009) Oluf Dimitri Røe et al. LUNG CANCER
- p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos
- (2009) Pascal Andujar et al. LUNG CANCER
- Loss of the Tumor Suppressor Gene NF2, Encoding Merlin, Constitutively Activates Integrin-Dependent mTORC1 Signaling
- (2009) M. A. Lopez-Lago et al. MOLECULAR AND CELLULAR BIOLOGY
- Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects
- (2009) Alla V Ivanova et al. Molecular Cancer
- The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival
- (2009) M Cheung et al. ONCOGENE
- Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?
- (2009) Marie-Claude F Jaurand et al. Particle and Fibre Toxicology
- Global Gene Expression Profiling Of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour Target
- (2009) Stefania Crispi et al. PLoS One
- Activated TNF- /NF- B signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice
- (2009) D. A. Altomare et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR Mediates Survival Signals in Malignant Mesothelioma Grown as Tumor Fragment Spheroids
- (2008) Shannon M. Wilson et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- National Mesothelioma Virtual Bank: A standard based biospecimen and clinical data resource to enhance translational research
- (2008) Waqas Amin et al. BMC CANCER
- Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
- (2008) David M. Jackman et al. CANCER
- Down-regulation of Inhibition of Differentiation-1 via Activation of Activating Transcription Factor 3 and Smad Regulates REIC/Dickkopf-3-Induced Apoptosis
- (2008) Y. Kashiwakura et al. CANCER RESEARCH
- Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical Outcome
- (2008) B. C. Christensen et al. CANCER RESEARCH
- YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation
- (2008) Toshihiko Yokoyama et al. CARCINOGENESIS
- Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma
- (2008) B. C. Christensen et al. CARCINOGENESIS
- Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma
- (2008) R. Villa et al. CLINICAL CANCER RESEARCH
- PTEN expression is a strong predictor of survival in mesothelioma patients☆
- (2008) Isabelle Opitz et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts
- (2008) James E. Littlejohn et al. INTERNATIONAL JOURNAL OF CANCER
- Genomic events associated with progression of pleural malignant mesothelioma
- (2008) Sergey V. Ivanov et al. INTERNATIONAL JOURNAL OF CANCER
- A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer
- (2008) Hedy Lee Kindler et al. INVESTIGATIONAL NEW DRUGS
- Mammalian Target of Rapamycin Contributes to the Acquired Apoptotic Resistance of Human Mesothelioma Multicellular Spheroids
- (2008) Dario Barbone et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional inactivation of NF2/merlin in human mesothelioma
- (2008) Claudio Thurneysen et al. LUNG CANCER
- Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
- (2008) Sanja Dacic et al. VIRCHOWS ARCHIV
- EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors
- (2007) H Kothmaier et al. THORAX
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started